Last updated on February 2019

Treatment of Pancreatic Cancer With Abraxane


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Metastatic Pancreatic Cancer
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Metastatic pancreatic carcinoma
  2. Age > 18 years
  3. Signed Informed Consent
  4. Normal hepatic, renal and Bone Marrow functions

Exclusion Criteria:

  1. Pregnant and lactating females 2. Previous treatment for metastatic pancreatic disease
  2. Known hypersensitivity to nab-paclitaxel 4. Neutrophils < 1,5 x 10^9/L

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.